Abbott Wins Marketing Clearance for First Smartphone-Compatible Cardiac Monitor

The FDA cleared Abbott’s launch of the first smartphone-compatible insertable cardiac monitor.

The Confirm Rx allows patients to connect the implant to their smartphone using Abbott’s myMerlin mobile app to enable continuous monitoring of their heart rhythms.

The data collected are transmitted to a physician via the mobile app on a set schedule.